BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Personalized medicine
,
Vitamin E
,
rs6983267
,
PTEN
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myeloma cells
Summary
General Info
Curated Studies
Most Correlated Studies
MMRC expression reference collection of newly diagnosed and relapsed multiple myeloma patients
Lymphoma, leukemia and myeloma cells treated with BET bromodomain BRD4 inhibitor AZD5153
Gene expression profiling of multiple myeloma cells with beta-catenin knockdown
GSK cancer cell line transcript profiling
Multiple myeloma cells with WT, mutant or null p53 status treated with PRIMA-1Met
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting Multiple Myeloma Cancer Stem Cells with Natural Products - Lessons from Other Hematologica…
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell dis…
Proteomic analysis of oridonin-induced apoptosis in multiple myeloma cells.
Loss of FAM46C Promotes Cell Survival in Myeloma.
Flunarizine exhibits in vitro efficacy against lymphoma and multiple myeloma cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Collection of Transplant Stem Cells for Plasma Cell Myeloma
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transpl…
CART-BCMA Cells for Multiple Myeloma
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma C…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ